Results 21 to 30 of about 25,600 (227)

Carbapenem-resistant Acinetobacter baumannii outbreak at university hospital [PDF]

Brazilian Journal of Microbiology, 2009
Nineteen clonally related imipenem-resistant Acinetobacter baumannii isolates were recovered from eight intensive care unit patients. All isolates harboured bla OXA-51-like β-lactamase genes and showed the absence of 22 kDa fraction in outer membrane porin profile analysis.
Takagi, E.H., Lincopan, N., Cassettari, V.C., Passadore, L.F., Mamizuka, E.M., Martinez, M.B.   +5 more
openaire   +4 more sources

Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance [PDF]

Clinical Infectious Diseases, 2015
With an increase in the use of colistin methansulfonate (CMS) to treat carbapenem-resistant Acinetobacter baumannii infections, colistin resistance is emerging.Patients with infection or colonization due to colistin-resistant A. baumannii were identified at a hospital system in Pennsylvania. Clinical data were collected from electronic medical records.
Zubair A, Qureshi, Lauren E, Hittle, Jessica A, O'Hara, Jesabel I, Rivera, Alveena, Syed, Ryan K, Shields, Anthony W, Pasculle, Robert K, Ernst, Yohei, Doi   +8 more
openaire   +2 more sources

The transmission of nosocomial pathogens in an intensive care unit: a space–time clustering and structural equation modelling approach [PDF]

, 2010
We investigated the incidence of cases of nosocomial pathogens and risk factors in an intensive treatment unit ward to determine if the number of cases is dependent on location of patients and the colonization/infection history of the ward.
Sheridan, E. A., Rushton, Steven, Lanyon, Clare, O'Donnell, Anthony, Shirley, Mark   +4 more
core   +1 more source

Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the β-Lactamase Inhibitor LN-1-255 against Acinetobacter spp.

Antibiotics, 2021
Treatment of infections caused by Acinetobacter spp., particularly A. baumannii, is a major clinical problem due to its high rates of antibiotic resistance.
Cristina Lasarte-Monterrubio, Juan C. Vázquez-Ucha, Maria Maneiro, Jorge Arca-Suárez, Isaac Alonso, Paula Guijarro-Sánchez, John D. Buynak, Germán Bou, Concepción González-Bello, Alejandro Beceiro   +9 more
doaj   +1 more source

Comparative in vitro activity of sitafloxacin against bacteremic isolates of carbapenem resistant Acinetobacter baumannii complex [PDF]

, 2017
Background: The emergence of carbapenem-resistant Acinetobacter baumannii (CRAB) complex has posed a great challenge to clinicians worldwide. Sitafloxacin has been shown to have in vitro activity against pathogens resistant to other fluoroquinolones ...
Huang, Yu-Shan;Wang, Jann-Tay;Sheng, Wang-Huei;Chuang, Yu-Chung;Chang, Shan-Chwen, 張上淳;盛望徽;王振泰;莊祐中   +1 more
core   +1 more source

Antimicrobial Activity of a Repurposed Harmine-Derived Compound on Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates

Frontiers in Cellular and Infection Microbiology, 2022
ObjectivesThe spread of antibiotic resistant bacteria is an important threat for human health. Acinetobacter baumannii bacteria impose such a major issue, as multidrug- to pandrug-resistant strains have been isolated, rendering some infections ...
Anke Breine, Anke Breine, Mégane Van Gysel, Mathias Elsocht, Clémence Whiteway, Clémence Whiteway, Chantal Philippe, Théo Quinet, Théo Quinet, Adam Valcek, Adam Valcek, Johan Wouters, Steven Ballet, Charles Van der Henst, Charles Van der Henst   +14 more
doaj   +1 more source

Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment [PDF]

Clinical Microbiology and Infection, 2019
Carbapenem-resistant Acinetobacter baumannii (CRAB) has gained global notoriety as a critically important nosocomial pathogen. It mostly affects debilitated patients, causing pneumonia and bloodstream infections with high mortality rates. Difficulties in treating CRAB infections stem from a formidable resistance profile that leaves available only a few
Piperaki, E.-T., Tzouvelekis, L.S., Miriagou, V., Daikos, G.L.   +3 more
openaire   +3 more sources

Characteristics of a Carbapenem-Resistant Acinetobacter baumannii Strain Causing Community-Acquired Pneumonia in a Young Healthy Women [PDF]

, 2023
Yan Chen,1 Liqun Xu,2 Jianfeng Wang3,4 1Department of General Practice, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang Province, People’s Republic of China ...
Xu L, Chen Y, Wang J
core  

Early dissemination of OXA-72-producing Acinetobacter baumannii strain in Colombia: a case report

Brazilian Journal of Infectious Diseases, 2014
Nosocomial infections caused by carbapenem-resistant Acinetobacter baumannii isolates have reached epidemic levels in past decades. Currently this microorganism is responsible for outbreaks of difficult eradication and with high mortality rates worldwide.
Sandra Yamile Saavedra, Rodrigo Cayô, Ana Cristina Gales, Aura Lucia Leal, Carlos Humberto Saavedra   +4 more
doaj   +1 more source

Polyvinylpyrrolidone-Capped Silver Nanoparticle Inhibits Infection of Carbapenem-Resistant Strain of Acinetobacter baumannii in the Human Pulmonary Epithelial Cell

Frontiers in Immunology, 2017
Acinetobacter baumannii, an opportunistic ESKAPE pathogen, causes respiratory and urinary tract infections. Its prevalence increases gradually in the clinical setup.
Vishvanath Tiwari, Monalisa Tiwari, Vandana Solanki   +2 more
doaj   +1 more source